Comparison

GRI977143 European Partner

Item no. HY-100676-5mg
Manufacturer MedChem Express
CASRN 325850-81-5
Amount 5 mg
Quantity options 100 mg 10 mg 1 ea 25 mg 50 mg 5 mg
Category
Type Inhibitor
Specific against other
Purity 99.84
Formula C22H17NO4S
Citations [1]Gyöngyi N. Kiss, et al. Virtual Screening for LPA2-Specific Agonists Identifies a Nonlipid Compound with Antiapoptotic Actions. Mol Pharmacol. 2012 Dec; 82(6): 1162–1173.<br/>[2]Gyöngyi Nagyné Kiss, et al. PHARMACOLOGICAL AND CELLULAR CHARACTERIZATION OF GRI977143, A NOVEL NONLIPID LPA2 RECEPTOR AGONIST IDENTIFIED BY VIRTUAL SCREENING.
Smiles O=C(O)C1=CC=CC=C1SCCCN(C(C2=CC=CC3=CC=CC4=C23)=O)C4=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
GRI977143 is a specific LPA2 receptor agonist, with an EC50 of 3.3 μM [1].
StorageTemperature
4°C (Powder, protect from light)
Shipping
Room Temperature
Manufacturers Applications
COVID-19-immunoregulation
MolecularWeight
391.44
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer; Inflammation/Immunology
Solubility
DMSO : 50 mg/mL (ultrasonic)
Target
Caspase; LPL Receptor
Manufacturers Target
Caspase; LPL Receptor
Isoform
LPAR2
Manufacturers Pathway
Apoptosis; GPCR/G Protein
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close